Disease × agent pairs

Non-Hodgkin Lymphoma (NHL): candidate agents with evidence

8 agents linked to Non-Hodgkin Lymphoma by at least one registered trial or two publications, ranked by the OSMF evidence score. Not treatment advice.

Research Tracker › Pairs › Non-Hodgkin Lymphoma (NHL)
Open Non-Hodgkin Lymphoma (NHL) in the Repurposing ExplorerNon-Hodgkin Lymphoma (NHL) hub

Blinatumomab

Drug · tier A · 8 trials (5 recruiting) · 5 publications · score 57.0

Busulfan

Drug · tier A · 8 trials (1 recruiting) · 3 publications · score 54.0

Epirubicin

Drug · tier A · 8 trials (1 recruiting) · 3 publications · score 49.5

Atezolizumab

Drug · tier A · 8 trials (1 recruiting) · 3 publications · score 48.0

Sirolimus

Drug · tier A · 8 trials (0 recruiting) · 0 publications · score 42.0

Tacrolimus Anhydrous

Drug · tier A · 8 trials (1 recruiting) · 0 publications · score 41.5

Bosutinib

Drug · tier A · 1 trials (1 recruiting) · 0 publications · score 24.0

Asciminib

Drug · tier A · 1 trials (1 recruiting) · 0 publications · score 23.5

Research map, not treatment advice. Built 2026-10-07.